Clinical Trial

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Name: A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis — clinical trial record (NCT07548840)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on hemodialysis

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-16

Trial Details

NCT Number	NCT07548840
Lead Sponsor	Taisho Pharmaceutical Co., Ltd.
Conditions	Hyperphosphatemia Patients on Hemodialysis
Enrollment	30 participants
Start Date	2026-05-08
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-15